Publication | Closed Access
Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer
18
Citations
29
References
2018
Year
HepatologyHepatocellular CarcinomaMedicineHepatobiliary TumorPharmacologyCancer GenomicsLiver CancerPharmacogenomic Data RevealsOncologyRadiation OncologyTumor MicroenvironmentCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1